Clinical Trials List
2017-06-01 - 2024-04-08
Phase III
Terminated9
ICD-10C16
Malignant neoplasm of stomach
ICD-10D00
Carcinoma in situ of oral cavity, esophagus and stomach
-
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yau-Lin Tseng Division of Thoracic Surgery
- 劉奕廷 Division of Hematology & Oncology
- Yi-Ting Yen Division of Thoracic Surgery
- Nai-Jung Chiang Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Huey-En Tzeng Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
2 Terminated
Audit
None
Co-Principal Investigator
- 張鈞弼 Division of Radiology
- Chi-Ting Liau Division of Hematology & Oncology
- Yu-Chuan Chang Division of Nuclear Medicine
- 陳煥武 Division of Radiology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Chi-Ju Yeh Division of Others -
- Mengting Peng Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- 柯萬盛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
749 participants
